High expression of PD-L1 has been found in cancer cells of NSCLC patients, and CAR T cells that secrete the anti-PD-L1 antibody have demonstrated promising efficacy in humanized mouse models20–22. The gene discussed is CD274; the disease is non-small cell lung carcinoma.